FDA Orange Book
Generic for Sensipar
Sensipar contains cinacalcet. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Sensipar is cinacalcet. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Sensipar and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Sensipar products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 30MG BASE | Discontinued | None | 9 | AB |
| tablet, oral | EQ 60MG BASE | Discontinued | None | 9 | AB |
| tablet, oral | EQ 90MG BASE | Discontinued | None | 9 | AB |
NDA 021688, held by AMGEN INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic cinacalcet
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AUROBINDO PHARMA LTD | 206125 | AB (A-rated, therapeutically equivalent) | March 8, 2018 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| CIPLA LTD | 208915 | AB (A-rated, therapeutically equivalent) | March 8, 2018 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| STRIDES PHARMA GLOBAL PTE LTD | 209226 | AB (A-rated, therapeutically equivalent) | April 30, 2018 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| PIRAMAL HEALTHCARE UK LTD | 210207 | AB (A-rated, therapeutically equivalent) | August 1, 2018 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | 204377 | AB (A-rated, therapeutically equivalent) | December 27, 2018 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| ALKEM LABORATORIES LTD | 210570 | AB (A-rated, therapeutically equivalent) | May 17, 2019 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| ACCORD HEALTHCARE INC | 211892 | AB (A-rated, therapeutically equivalent) | May 15, 2020 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| CHARTWELL RX SCIENCES LLC | 213325 | AB (A-rated, therapeutically equivalent) | May 18, 2020 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
| DR REDDYS LABORATORIES LTD | 208368 | AB (A-rated, therapeutically equivalent) | September 18, 2020 | EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE |
Sensipar patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7829595 | September 22, 2026 | Drug product | U-1098 | 021688 |
| 9375405 | September 22, 2026 | Drug product | None | 021688 |
Sensipar NDC codes
Questions
Is there a generic for Sensipar?
Yes. The generic name for Sensipar is cinacalcet. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Sensipar?
The active ingredient in Sensipar is cinacalcet, per the FDA Orange Book.
When does the Sensipar patent expire?
The last patent listed for Sensipar in the Orange Book expires September 22, 2026. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.